Targeted Nanoparticle Delivery of Bifunctional RIG-I Agonists to Pancreatic Cancer

Mol Ther. 2019 Mar 6;27(3):491-492. doi: 10.1016/j.ymthe.2019.02.005. Epub 2019 Feb 20.

Authors

Thomas Zillinger¹, Gunther Hartmann²

Affiliations

¹ Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital, University of Bonn, Bonn, Germany.
² Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital, University of Bonn, Bonn, Germany. Electronic address: gunther.hartmann@ukb.uni-bonn.de.

No abstract available

Publication types

Comment

MeSH terms

Humans
Nanoparticles*
Pancreatic Neoplasms*